SB-710411: is purported to block U-II-induced contractions in rat isolated aorta, little is known about its specific pharmacological properties [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 9898353 |
| MeSH ID | M0449038 |
| Synonym |
|---|
| sb-710411 |
| l-phenylalaninamide,4-chloro-l-phenylalanyl-d-cysteinyl-3-(3-pyridinyl)-l-alanyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-4-chloro-,cyclic (2?7)-disulfide |
| 209006-05-3 |
| l-phenylalaninamide, 4-chloro-l-phenylalanyl-d-cysteinyl-3-(3-pyridinyl)-l-alanyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-4-chloro-, cyclic (2-7)-disulfide |
| sb 710411 |
| cpa-c(d-cys-pal-d-trp-lys-val-cys)-cpa-amide |
| chlorophenylalanyl-cyclo(cysteinyl-1-oxohexadecyl-tryptophyl-lysyl-valyl-cysteinyl)-chlorophenylalanylamide |
| (4r,7s,10s,13r,16s,19s)-10-(4-aminobutyl)-n-[(2s)-1-amino-3-(4-chlorophenyl)-1-oxopropan-2-yl]-19-[[(2s)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-16-(pyridin-3-ylmethyl)-1,2-dithia-5,8,11,14,1 |
| l-phenylalaninamide,4-chloro-l-phenylalanyl-d-cysteinyl-3-(3-pyridinyl)-l-alanyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-4-chloro-,cyclic(2(r)7)-disulfide |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.33) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||